Orthwein Alexandre, Noordermeer Sylvie M, Wilson Marcus D, Landry Sébastien, Enchev Radoslav I, Sherker Alana, Munro Meagan, Pinder Jordan, Salsman Jayme, Dellaire Graham, Xia Bing, Peter Matthias, Durocher Daniel
The Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario M5G 1X5, Canada.
ETH Zurich, Institute of Biochemistry, Department of Biology, Otto-Stern-Weg 3, CH-8093 Zurich, Switzerland.
Nature. 2015 Dec 17;528(7582):422-6. doi: 10.1038/nature16142. Epub 2015 Dec 9.
DNA repair by homologous recombination is highly suppressed in G1 cells to ensure that mitotic recombination occurs solely between sister chromatids. Although many homologous recombination factors are cell-cycle regulated, the identity of the events that are both necessary and sufficient to suppress recombination in G1 cells is unknown. Here we report that the cell cycle controls the interaction of BRCA1 with PALB2-BRCA2 to constrain BRCA2 function to the S/G2 phases in human cells. We found that the BRCA1-interaction site on PALB2 is targeted by an E3 ubiquitin ligase composed of KEAP1, a PALB2-interacting protein, in complex with cullin-3 (CUL3)-RBX1 (ref. 6). PALB2 ubiquitylation suppresses its interaction with BRCA1 and is counteracted by the deubiquitylase USP11, which is itself under cell cycle control. Restoration of the BRCA1-PALB2 interaction combined with the activation of DNA-end resection is sufficient to induce homologous recombination in G1, as measured by RAD51 recruitment, unscheduled DNA synthesis and a CRISPR-Cas9-based gene-targeting assay. We conclude that the mechanism prohibiting homologous recombination in G1 minimally consists of the suppression of DNA-end resection coupled with a multi-step block of the recruitment of BRCA2 to DNA damage sites that involves the inhibition of BRCA1-PALB2-BRCA2 complex assembly. We speculate that the ability to induce homologous recombination in G1 cells with defined factors could spur the development of gene-targeting applications in non-dividing cells.
在G1期细胞中,同源重组介导的DNA修复受到高度抑制,以确保有丝分裂重组仅发生在姐妹染色单体之间。尽管许多同源重组因子受细胞周期调控,但在G1期细胞中抑制重组所必需且充分的事件的身份尚不清楚。在这里,我们报告细胞周期控制BRCA1与PALB2-BRCA2的相互作用,以将BRCA2的功能限制在人类细胞的S/G2期。我们发现,PALB2上的BRCA1相互作用位点被一种E3泛素连接酶靶向,该酶由KEAP1(一种与PALB2相互作用的蛋白质)与cullin-3(CUL3)-RBX1组成复合物(参考文献6)。PALB2的泛素化抑制了它与BRCA1的相互作用,而去泛素化酶USP11可以抵消这种作用,USP11本身也受细胞周期控制。通过RAD51募集、非计划DNA合成和基于CRISPR-Cas9的基因靶向分析测量,BRCA1-PALB2相互作用的恢复与DNA末端切除的激活相结合足以在G1期诱导同源重组。我们得出结论,在G1期禁止同源重组的机制至少包括抑制DNA末端切除,以及对BRCA2募集到DNA损伤位点的多步骤阻断,这涉及抑制BRCA1-PALB2-BRCA2复合物的组装。我们推测,用特定因子在G1期细胞中诱导同源重组的能力可能会促进非分裂细胞中基因靶向应用的发展。